The Hematologist

banner image

2019 Year's Best

Our Contributing Editors provide coverage of the most influential breakthroughs of 2019 for the field of hematology.

Read more
banner image

Unwrapping the Best From Hematology's "Christmas"

2019 ASH News Daily Editor Dr. Ayesha Zia recaps the 61st ASH Annual Meeting and Exposition, which took place early December in Orlando.

Read more
banner image

Ask the Hematologists

Drs. Gaurav Goyal and Ronald Go discuss the diagnosis and management of Erdheim-Chester disease, a MAPK-ERK pathway-driven histiocytic neoplasm.

Read more
Current Issue Static Feature

Current Issue

January/February 2020
Volume 17, Issue 1

Read current issue

President's Column

Presidents Column - Stephanie Lee Member of the Fred Hutchinson Cancer Research Center and Professor at the University of Washington in Seattle, WA
Momentum: "Strength Gained by a Series of Events"
January 27, 2020

In her inaugural President's Column, 2020 ASH President Dr. Stephanie Lee previews the year ahead at ASH and reviews some of the breakthroughs of the past decade.

View all president's column articles

  • CAR T-cell Therapy: An Update on Coverage and Reimbursement
    August 14, 2019

    ASH continues to advocate for adequate coverage and reimbursement for chimeric antigen receptor T-cell (CAR-T) therapy. In early August, the Centers for Medicare and Medicaid Services (CMS) finalized policies impacting both reimbursement of and coverage for CAR-T therapy. The final Inpatient Prospective Payment System (IPPS) rule, published on August 2, and the final Decision Memo for CAR T-cell Therapy for Cancers, issued August 7.

  • 2018 ASH Advocacy Activities
    December 11, 2018

    ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.

  • 2018 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait
    December 11, 2018

    ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2018.

  • 2018 ASH Advocacy Efforts to Ensure Patient Access to Care
    December 11, 2018

    In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.

View all Policy News